BioLineRx Company Profile (NASDAQ:BLRX)

About BioLineRx

BioLineRx logoBioLine RX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates under development consist of BL-1020 that is in Phase II/III clinical trials to improve cognitive function in schizophrenia patients; BL-1040, which is under pivotal CE-Mark registration trial for the prevention of cardiac remodeling following an acute myocardial infarction; BL-5010, which has completed Phase I/II clinical trials for non-surgical removal of skin lesions; BL-1021 that has completed Phase Ia clinical trial for the treatment of neuropathic pain or pain that results from damage to nerve fibers, and BL-7040, a synthetic oligonucleotide, which is in Phase II clinical trial for the treatment of inflammatory bowel disease. The Company also has 11 pre-clinical stage development products for various indications.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BLRX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.92
  • 50 Day Moving Average: $0.8250
  • 200 Day Moving Average: $0.9295
  • 52-Week Range: $0.71 - $1.88
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.00
  • P/E Growth: 0.0000
  • Market Cap: $50.58M
  • Outstanding Shares: 56,423,000
  • Beta: 1.77
Additional Links:
Companies Related to BioLineRx:

Analyst Ratings

Consensus Ratings for BioLineRx (NASDAQ:BLRX) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $3.50 (288.89% upside)

Analysts' Ratings History for BioLineRx (NASDAQ:BLRX)
Show:
DateFirmActionRatingPrice TargetDetails
8/14/2016Roth CapitalReiterated RatingBuy$7.00View Rating Details
8/12/2016Maxim GroupDowngradeBuy -> Hold$4.00 -> $1.00View Rating Details
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$3.50 -> $3.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$3.50 -> $3.00View Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for BioLineRx (NASDAQ:BLRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/11/2016Q216($0.07)($0.09)ViewListenView Earnings Details
5/17/2016Q116($0.08)($0.10)ViewListenView Earnings Details
3/10/2016Q415($0.06)($0.07)ViewListenView Earnings Details
11/16/2015Q315($0.08)($0.03)ViewListenView Earnings Details
8/20/2015Q215($0.10)($0.09)ViewListenView Earnings Details
5/18/2015Q115($0.10)($0.08)ViewListenView Earnings Details
11/10/2014Q314($0.17)($0.01)ViewN/AView Earnings Details
8/6/2014Q214($0.09)($0.12)ViewN/AView Earnings Details
5/20/2014Q114($0.11)($0.01)ViewN/AView Earnings Details
3/17/2014($0.15)($0.20)ViewN/AView Earnings Details
11/13/2013($0.18)($0.20)ViewN/AView Earnings Details
8/6/2013Q213($0.02)ViewN/AView Earnings Details
5/7/2013($0.02)($0.20)ViewN/AView Earnings Details
11/14/2012Q312($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioLineRx (NASDAQ:BLRX)
Current Year EPS Consensus Estimate: $-0.26 EPS
Next Year EPS Consensus Estimate: $-0.18 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.08)($0.08)($0.08)
Q2 20161($0.07)($0.07)($0.07)
Q3 20161($0.07)($0.07)($0.07)
Q4 20161($0.08)($0.08)($0.08)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for BioLineRx (NASDAQ:BLRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioLineRx (NASDAQ:BLRX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for BioLineRx (NASDAQ:BLRX)
DateHeadline
marketwatch.com logoBioLineRx to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York (NASDAQ:BLRX)
www.marketwatch.com - August 29 at 8:37 AM
streetinsider.com logoBioLineRx (BLRX), I-Bridge Capital Form New JV in China - StreetInsider.com (NASDAQ:BLRX)
www.streetinsider.com - August 27 at 8:40 AM
4-traders.com logoBioLineRx : and I-Bridge Capital Establish a New Drug Development Joint Venture in China (NASDAQ:BLRX)
www.4-traders.com - August 25 at 9:18 PM
News IconBioLineRx and I-Bridge Capital launch new joint venture (NASDAQ:BLRX)
www.pehub.com - August 25 at 3:55 PM
streetinsider.com logoBioLineRx (BLRX), I-Bridge Capital Form New JV in China (NASDAQ:BLRX)
www.streetinsider.com - August 25 at 8:44 AM
publicnow.com logoBioLineRx and I-Bridge Capital Establish a New Drug Development Joint Venture in China (NASDAQ:BLRX)
www.publicnow.com - August 25 at 8:44 AM
stocksdaily.net logoCan BioLineRx Ltd. (NASDAQ:BLRX) Meet Analysts Expectations? - Stocks Daily (NASDAQ:BLRX)
www.stocksdaily.net - August 20 at 3:54 PM
stocksdaily.net logoWill BioLineRx Ltd. (NASDAQ:BLRX) Surprise Analysts This Quarter? - Stocks Daily (NASDAQ:BLRX)
www.stocksdaily.net - August 14 at 8:41 AM
finance.yahoo.com logoBioLineRx downgraded by Maxim Group (NASDAQ:BLRX)
finance.yahoo.com - August 12 at 12:32 PM
finance.yahoo.com logoBioLineRx Reports Second Quarter 2016 Financial Results (NASDAQ:BLRX)
finance.yahoo.com - August 11 at 12:01 PM
4-traders.com logoBioLineRx : Signs Second Clinical Immuno-Oncology Collaboration Agreement to Investigate Combination of BL-8040 and KEYTRUDA® for Pancreatic Cancer (NASDAQ:BLRX)
www.4-traders.com - August 8 at 3:56 PM
publicnow.com logoBioLineRx Signs Second Clinical Immuno-Oncology Collaboration Agreement to Investigate Combination of BL-8040 and KEYTRUDA® for Pancreatic Cancer (NASDAQ:BLRX)
www.publicnow.com - August 8 at 8:41 AM
publicnow.com logoBioLineRx to Report Second Quarter Results on August 11, 2016 (NASDAQ:BLRX)
www.publicnow.com - August 4 at 12:27 PM
marketexclusive.com logoNovartis AG (NYSE:NVS)’s Partner Bioline RX Announce In-Licensing Of Liver Fibrosis Project (NASDAQ:BLRX)
marketexclusive.com - August 3 at 3:54 PM
News IconNews Review - Bioline RX Ltd (NASDAQ:BLRX) - Hot Stocks Point (NASDAQ:BLRX)
www.hotstockspoint.com - August 2 at 8:41 AM
twst.com logoBioLineRX Ltd.: BioLineRx Announces In-licensing of Liver Fibrosis Project Under Strategic Collaboration (NASDAQ:BLRX)
www.twst.com - August 1 at 8:46 AM
publicnow.com logoBioLineRx Announces In-licensing of Liver Fibrosis Project Under Strategic Collaboration (NASDAQ:BLRX)
www.publicnow.com - August 1 at 7:21 AM
News IconBiolinerx Limited Ads (NASDAQ:BLRX) Short Interest Decreased By 42.65% - Consumer Eagle (NASDAQ:BLRX)
www.consumereagle.com - July 16 at 3:49 PM
News IconBiolinerx Limited Ads (NASDAQ:BLRX) Shorts Decreased by 42.65% After Short Covering - Press Telegraph (NASDAQ:BLRX)
presstelegraph.com - July 15 at 2:29 PM
News IconAnalyst Target and Average Rating Watch: BioLineRx Ltd. (NASDAQ:BLRX) - Press Telegraph (NASDAQ:BLRX)
presstelegraph.com - July 15 at 2:29 PM
News IconBioLineRx Ltd. (NASDAQ:BLRX) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:BLRX)
telanaganapress.com - July 13 at 3:53 PM
fiscalstandard.com logoBioLineRx Ltd. (BLRX) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:BLRX)
www.fiscalstandard.com - July 10 at 3:48 PM
fiscalstandard.com logoBioLineRx Ltd. (BLRX) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:BLRX)
www.fiscalstandard.com - July 10 at 3:48 PM
News IconCan BioLineRx Ltd. (NASDAQ:BLRX) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:BLRX)
www.engelwooddaily.com - July 9 at 3:44 PM
News IconCompany Stock Focus for BioLineRx Ltd. (NASDAQ:BLRX): Which Way Will Shares Head? - Press Telegraph (NASDAQ:BLRX)
presstelegraph.com - July 9 at 3:44 PM
News IconBioLineRx Ltd. (NASDAQ:BLRX) Stock Update: Check on Ratings and Target Price - Telanagana Press (NASDAQ:BLRX)
telanaganapress.com - July 6 at 9:40 PM
fiscalstandard.com logoBroker Outlook For The Week Ahead BioLineRx Ltd. (BLRX) - Fiscal Standard (NASDAQ:BLRX)
www.fiscalstandard.com - July 4 at 3:49 PM
fiscalstandard.com logoBioLineRx Ltd. (BLRX) Current Analyst Ratings - Fiscal Standard (NASDAQ:BLRX)
www.fiscalstandard.com - July 1 at 11:55 AM
ftsenews.co.uk logoNew Broker Ratings For BioLineRx Ltd. (BLRX) - FTSE News (NASDAQ:BLRX)
www.ftsenews.co.uk - July 1 at 11:55 AM
News IconBioLineRx Ltd. (NASDAQ:BLRX) Company Rating and Target Watch - Telanagana Press (NASDAQ:BLRX)
telanaganapress.com - June 29 at 8:57 PM
News IconBiolinerx Limited Ads (NASDAQ:BLRX) Shorts Decreased by 42.65% After Short Covering - Engelwood Daily (NASDAQ:BLRX)
www.engelwooddaily.com - June 29 at 8:57 PM
smarteranalyst.com logoStock Update (NASDAQ:BLRX): Bioline RX Ltd Announces Regulatory Submissions for Phase 2a Trial of BL-8040 in ... - Smarter Analyst (NASDAQ:BLRX)
www.smarteranalyst.com - June 28 at 4:05 PM
streetinsider.com logoBioLineRx (BLRX) Submits Regulatory Filings Needed to Commence BL-8040 Combo Phase 2a in Pancreatic Cancer - StreetInsider.com (NASDAQ:BLRX)
www.streetinsider.com - June 28 at 8:20 AM
finance.yahoo.com logo7:15 am BioLineRx announces the filing of regulatory submissions required to commence a Phase 2a trial for BL-8040 in combination with KEYTRUDA for the treatment of patients with pancreatic cancer (NASDAQ:BLRX)
finance.yahoo.com - June 28 at 7:15 AM
finance.yahoo.com logoBioLineRx Announces Regulatory Submissions for Phase 2a Trial of BL-8040 in Combination with KEYTRUDA® (pembrolizumab) for Treatment of Pancreatic Cancer (NASDAQ:BLRX)
finance.yahoo.com - June 28 at 7:00 AM
News IconShare Update and Earnings Review for BioLineRx Ltd. (NASDAQ:BLRX) - Press Telegraph (NASDAQ:BLRX)
presstelegraph.com - June 27 at 8:32 AM
News IconHow Many Bioline RX Ltd (NASDAQ:BLRX)'s Analysts Are Bullish? - Engelwood Daily (NASDAQ:BLRX)
www.engelwooddaily.com - June 26 at 3:42 PM
News IconBioLineRx Ltd. (NASDAQ:BLRX) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:BLRX)
www.engelwooddaily.com - June 24 at 3:52 PM
News IconCovering the Bases on BioLineRx Ltd. (NASDAQ:BLRX): Where is the Stock Going? - Press Telegraph (NASDAQ:BLRX)
presstelegraph.com - June 24 at 7:28 AM
ftsenews.co.uk logoBioLineRx Ltd. (BLRX) Updated Price Targets - FTSE News (NASDAQ:BLRX)
www.ftsenews.co.uk - June 22 at 9:05 PM
fiscalstandard.com logoBrokers Issue Average Price Target Of 4.50 On BioLineRx Ltd. (BLRX) - Fiscal Standard (NASDAQ:BLRX)
www.fiscalstandard.com - June 21 at 3:47 PM
kcregister.com logoBioLineRx, Ltd. (NASDAQ:BLRX) decreased -2.09%: Verizon Communications Inc. (NYSE:VZ), United Continental ... - KC Register (NASDAQ:BLRX)
www.kcregister.com - June 17 at 3:47 PM
publicnow.com logoBioLineRx to Present at the JMP Securities Life Sciences Conference in New York (NASDAQ:BLRX)
www.publicnow.com - June 15 at 7:19 AM
News IconInvestment Analysts' Weekly Ratings Changes for Bioline RX (BLRX) - Let Me Know About This (NASDAQ:BLRX)
www.lmkat.com - June 3 at 9:57 PM
News IconBioLineRx Ltd. (BLRX) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News (NASDAQ:BLRX)
www.sharetrading.news - June 3 at 9:56 PM
News IconShare Rating Focus on BioLineRx Ltd. (NASDAQ:BLRX) - HNN (NASDAQ:BLRX)
hintsnewsnetwork.com - June 3 at 12:26 PM
News IconOne Small Step for Bioline RX (BLRX) is Actually One Big Step - SmallCap Network (NASDAQ:BLRX)
www.smallcapnetwork.com - June 2 at 3:59 PM
News IconTarget Price and Stock Performance Rundown for BioLineRx Ltd. (NASDAQ:BLRX) - HNN (NASDAQ:BLRX)
hintsnewsnetwork.com - June 2 at 12:37 PM
News IconStock Rating Review for BioLineRx Ltd. (NASDAQ:BLRX) - Wall Street Hints and News (NASDAQ:BLRX)
hintsnewsnetwork.com - May 27 at 1:18 AM
News IconTarget Check and Stock Performance Recap BioLineRx Ltd. (NASDAQ:BLRX) - Wall Street Hints and News (NASDAQ:BLRX)
hintsnewsnetwork.com - May 26 at 8:10 PM

Social

BioLineRx (NASDAQ:BLRX) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff